Head-to-head · WeighScore
Revive Meds vs Tell Her Doc
The verdict
Tell Her Doc takes it — 57.4/100 to 56.9/100, but only just.
Tell Her Doc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses. Revive Meds is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Revive Meds | Tell Her Doc |
|---|---|---|
| WeighScore | 56.9/100 | 57.4/100 |
| Grade | C | C |
| Scorecard rank | #404 | #400 |
| Semaglutide | $369/mo (starting dose, compounded) | $269/mo (microdose tier, plus a separate fee, compounded) |
| Tirzepatide | $459/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #404 · C
Strengths
- Offers both compounded semaglutide and dual-agonist tirzepatide, each combined with vitamin B12 (cyanocobalamin) in a single injection
- Pay-per-order model with no subscription, sign-up fees, or long-term commitment, and free shipping on every order
- Names its six 503A compounding pharmacies and two prescribing physicians, which is unusually transparent on fulfillment
- Available in all 50 states and HSA/FSA eligible through a Medical Necessity Letter
- Prepaying 3 to 12 months cuts the effective cost to as low as $202/mo (semaglutide) or $300/mo (tirzepatide)
Where it loses points
- Month-to-month pricing is steep: $369/mo semaglutide and $459/mo tirzepatide unless you prepay several months
- No public price list; pricing appears only after you complete a full health intake and create an account
- Not LegitScript-certified (no seal displayed on the site)
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #400 · C
Strengths
- Full compounded GLP-1 lineup — semaglutide and tirzepatide in injection, oral and orally-dissolving-tablet forms, plus microdoses
- Names its compounding pharmacy partner (Casa Pharma RX), which is independently listed in our pharmacy registry
- No monthly membership, cancel anytime, free discreet shipping; HSA/FSA eligible with buy-now-pay-later plans
- Serves patients in all 50 states via a private online consultation
Where it loses points
- 'All sales are final' — no refunds once medication has left the pharmacy
- Exact price is plan-dependent, shown after you pick a product; advertised 'starting at $269', with a lower $140 intro on oral semaglutide
- References LegitScript but without an independently verifiable seal — we couldn't confirm certification
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.